Not sure how you come to the conclusion of CF+ by next week from what MoonReach has set out in their post??
Their calculations are clearly assuming a full rollout to all of CC and Cap, which we already know won't be in place next week, given that in the webinar we were told about 50% of CC stores will have their B2C capability by June '24 and that the SaaS revenue from the commercial rollout to Cap members starts in 2nd half of '24 calendar year.
Why keep asking people to give their revenue predictions when all you're going do is try and discredit them by making ridiculous conclusions that are plainly not open from what the person has posted?
Why not instead have a discussion about the validity of the various assumptions that have been made in arriving at the revenue prediction as that is more likely to lead to some productive discourse that may benefit people on this forum
- Forums
- ASX - By Stock
- SPX
- Webinar questions
SPX
spenda limited
Add to My Watchlist
9.09%
!
0.6¢

Webinar questions, page-154
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.6¢ |
Change
0.001(9.09%) |
Mkt cap ! $27.69M |
Open | High | Low | Value | Volume |
0.6¢ | 0.7¢ | 0.6¢ | $23.32K | 3.880M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 280696 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 18216262 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 280696 | 0.006 |
48 | 22729523 | 0.005 |
8 | 15700000 | 0.004 |
9 | 26100000 | 0.003 |
5 | 17000002 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 17544441 | 26 |
0.008 | 3921694 | 23 |
0.009 | 9234397 | 15 |
0.010 | 842781 | 5 |
0.011 | 527004 | 4 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
SPX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online